Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Simvastatin Hydroxy Acid Ammonium - Amplicore

X
Drug Profile

Simvastatin Hydroxy Acid Ammonium - Amplicore

Alternative Names: AM-3101

Latest Information Update: 21 Nov 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Amplicore
  • Class Antihyperlipidaemics
  • Mechanism of Action HMG-CoA reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Meniscus disorders

Most Recent Events

  • 21 Nov 2022 Chemical structure information added
  • 29 Sep 2022 University of Cincinnati plans a phase I/II trial for Cartilage disorders in the US (NCT05560477)
  • 26 Mar 2021 Amplicore and University of Cincinnati plans an early stage clinical trial to evaluate the safety and efficacy of AM 3101 for Meniscus disorders (Adjuvant therapy)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top